![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:TIMP1-ADAMTS2 (FusionGDB2 ID:HG7076TG9509) |
Fusion Gene Summary for TIMP1-ADAMTS2 |
![]() |
Fusion gene information | Fusion gene name: TIMP1-ADAMTS2 | Fusion gene ID: hg7076tg9509 | Hgene | Tgene | Gene symbol | TIMP1 | ADAMTS2 | Gene ID | 7076 | 9509 |
Gene name | TIMP metallopeptidase inhibitor 1 | ADAM metallopeptidase with thrombospondin type 1 motif 2 | |
Synonyms | CLGI|EPA|EPO|HCI|TIMP|TIMP-1 | ADAM-TS2|ADAMTS-2|ADAMTS-3|EDSDERMS|NPI|PC I-NP|PCI-NP|PCINP|PCPNI|PNPI | |
Cytomap | ('TIMP1')('ADAMTS2') Xp11.3 | 5q35.3 | |
Type of gene | protein-coding | protein-coding | |
Description | metalloproteinase inhibitor 1collagenase inhibitorepididymis secretory sperm binding proteinerythroid potentiating activityfibroblast collagenase inhibitortissue inhibitor of metalloproteinases 1 | A disintegrin and metalloproteinase with thrombospondin motifs 2a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 2procollagen I N-proteinaseprocollagen I/II amino propeptide-processing enzymeprocollagen N-endo | |
Modification date | 20200315 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000218388, ENST00000456754, ENST00000377018, ENST00000377017, | ||
Fusion gene scores | * DoF score | 12 X 8 X 3=288 | 6 X 6 X 3=108 |
# samples | 12 | 6 | |
** MAII score | log2(12/288*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/108*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: TIMP1 [Title/Abstract] AND ADAMTS2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | TIMP1(47442862)-ADAMTS2(178582079), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | TIMP1 | GO:0008284 | positive regulation of cell proliferation | 3839290 |
Hgene | TIMP1 | GO:0010951 | negative regulation of endopeptidase activity | 3903517 |
Hgene | TIMP1 | GO:0043086 | negative regulation of catalytic activity | 3903517 |
Hgene | TIMP1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis | 12714508 |
Hgene | TIMP1 | GO:1905049 | negative regulation of metallopeptidase activity | 9573338 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Top |
Fusion Gene ORF analysis for TIMP1-ADAMTS2 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for TIMP1-ADAMTS2 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for TIMP1-ADAMTS2 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:47442862/:178582079) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for TIMP1-ADAMTS2 |
![]() |
Top |
Fusion Gene PPI Analysis for TIMP1-ADAMTS2 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for TIMP1-ADAMTS2 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for TIMP1-ADAMTS2 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | TIMP1 | C0023893 | Liver Cirrhosis, Experimental | 5 | CTD_human |
Hgene | TIMP1 | C0002152 | Alloxan Diabetes | 1 | CTD_human |
Hgene | TIMP1 | C0003504 | Aortic Valve Insufficiency | 1 | CTD_human |
Hgene | TIMP1 | C0004364 | Autoimmune Diseases | 1 | CTD_human |
Hgene | TIMP1 | C0005398 | Cholestasis, Extrahepatic | 1 | CTD_human |
Hgene | TIMP1 | C0006663 | Calcinosis | 1 | CTD_human |
Hgene | TIMP1 | C0008311 | Cholangitis | 1 | CTD_human |
Hgene | TIMP1 | C0011853 | Diabetes Mellitus, Experimental | 1 | CTD_human |
Hgene | TIMP1 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
Hgene | TIMP1 | C0017661 | IGA Glomerulonephritis | 1 | CTD_human |
Hgene | TIMP1 | C0018799 | Heart Diseases | 1 | CTD_human |
Hgene | TIMP1 | C0018824 | Heart valve disease | 1 | CTD_human |
Hgene | TIMP1 | C0019202 | Hepatolenticular Degeneration | 1 | CTD_human |
Hgene | TIMP1 | C0020538 | Hypertensive disease | 1 | CTD_human |
Hgene | TIMP1 | C0021368 | Inflammation | 1 | CTD_human |
Hgene | TIMP1 | C0023891 | Liver Cirrhosis, Alcoholic | 1 | CTD_human |
Hgene | TIMP1 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
Hgene | TIMP1 | C0029172 | Oral Submucous Fibrosis | 1 | CTD_human |
Hgene | TIMP1 | C0034069 | Pulmonary Fibrosis | 1 | CTD_human |
Hgene | TIMP1 | C0035222 | Respiratory Distress Syndrome, Adult | 1 | CTD_human |
Hgene | TIMP1 | C0038433 | Streptozotocin Diabetes | 1 | CTD_human |
Hgene | TIMP1 | C0042345 | Varicosity | 1 | CTD_human |
Hgene | TIMP1 | C0042373 | Vascular Diseases | 1 | CTD_human |
Hgene | TIMP1 | C0263628 | Tumoral calcinosis | 1 | CTD_human |
Hgene | TIMP1 | C0521174 | Microcalcification | 1 | CTD_human |
Hgene | TIMP1 | C1527352 | Hepatic Form of Wilson Disease | 1 | CTD_human |
Hgene | TIMP1 | C1720887 | Female Urogenital Diseases | 1 | CTD_human |
Hgene | TIMP1 | C4721507 | Alveolitis, Fibrosing | 1 | CTD_human |
Tgene | C2700425 | EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE | 2 | CTD_human;GENOMICS_ENGLAND;ORPHANET | |
Tgene | C0345967 | Malignant mesothelioma | 1 | CTD_human |